Cancer Risks For Mismatch Repair Gene Mutation Carriers: A Population-Based Early Onset Case-Family Study

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 4, 2006, Pages 489-498

  Jenkins, Mark A ^a   Baglietto, Laura ^b   Dowty, James G ^a   Van Vliet, Christine M ^a   Smith, Letitia ^a   Mead, Leeanne J ^a   Macrae, Finlay A ^d   St John, D James B ^d,e   Jass, Jeremy R ^f   Giles, Graham G ^a,b   Hopper, John L ^a   Southey, Melissa C ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e National Cancer Control Initiative   (Australia)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FAMILIAL CANCER; FAMILY; FAMILY HISTORY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MALE; MISMATCH REPAIR; POPULATION; RISK ASSESSMENT; SEGREGATION ANALYSIS;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATASES; ADULT; AGE FACTORS; BASE PAIR MISMATCH; CARRIER PROTEINS; COLORECTAL NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MALE; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PENETRANCE; RISK ASSESSMENT; SEX FACTORS;

EID: 33645826906     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.01.002     Document Type: Article

References (34)

1. Mitchell R.J., Farrington S.M., Dunlop M.G., et al. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer. a HuGE review. Am J Epidemiol 156 (2002) 885-902
2. Buttin B.M., Powell M.A., Mutch D.G., et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 74 (2004) 1262-1269
3. Froggatt N.J., Brassett C., Koch D.J., et al. Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. J Med Genet 33 (1996) 726-730
4. Vasen H.F., Wijnen J.T., Menko F.H., et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110 (1996) 1020-1027
5. Heinimann K., Muller H., Weber W., et al. Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindreds. Int J Cancer 74 (1997) 281-285
6. Pensotti V., Radice P., Presciuttini S., et al. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Genes Chromosomes Cancer 19 (1997) 135-142
7. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81 (1999) 214-218
8. Vasen H.F., Stormorken A., Menko F.H., et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers. a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19 (2001) 4074-4080
9. De Vos tot Nederveen Cappel W.H., Nagengast F.M., Griffioen G., et al. Surveillance for hereditary nonpolyposis colorectal cancer. a long-term study on 114 families. Dis Colon Rectum 45 (2002) 1588-1594
10. Green J., O'Driscoll M., Barnes A., et al. Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation. Dis Colon Rectum 45 (2002) 1223-1232
11. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
12. Carayol J., Khlat M., Maccario J., et al. Hereditary non-polyposis colorectal cancer. current risks of colorectal cancer largely overestimated. J Med Genet 39 (2002) 335-339
13. Quehenberger F., Vasen H.F.A., and van Houwelingen H.C. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene. correction for ascertainment. J Med Genet 42 (2005) 491-496
14. Thibodeau S.N., French A.J., Roche P.C., et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56 (1996) 4836-4840
15. Terdiman J.P., Gum Jr. J.R., Conrad P.G., et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 120 (2001) 21-30
16. Christensen M., Katballe N., Wikman F., et al. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 95 (2002) 2422-2430
17. Furukawa T., Konishi F., Shitoh K., et al. Evaluation of screening strategy for detecting hereditary nonpolyposis colorectal carcinoma. Cancer 94 (2002) 911-920
18. Ward R., Meldrum C., Williams R., et al. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer. J Cancer Res Clin Oncol 128 (2002) 403-411
19. Southey M.C., Jenkins M.A., Mead L., et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23 (2005) 6524-6532
20. Chai S.M., Zeps N., Shearwood A.M., et al. Screening for defective DNA mismatch repair in stage II and III colorectal cancer cases. Clin Gastroenterol Hepatol 2 (2004) 1017-1025
21. Hopper J.L. Application of genetics to the prevention of colorectal cancer. Recent Results Cancer Res 166 (2005) 17-33
22. Lenz H.-J. First Amsterdam, then Bethesda, now Melbourne?. J Clin Oncol 23 (2005) 6445-6449
23. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6 (1997) 105-110
24. Jenkins M.A., Baglietto L., Dite G.S., et al. After hMSH2 and hMLH1-what next? Analysis of three-generational, population-based, early-onset colorectal cancer families. Int J Cancer 102 (2002) 166-171
25. Vasen H.F., Watson P., Mecklin J.P., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116 (1999) 1453-1456
26. Schouten J.P., McElgunn C.J., Waajer R., et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30 (2002) e57
27. Lange K., Cantor R., Horvath S., et al. Mendel version 4.0. a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet 69 Suppl (2001) A1886
28. Australian Institute of Health and Welfare, Interactive cancer data. Available at: http://www.aihw.gov.au/cancer/datacubes/index.cfm.
29. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries 2004. Cancer in Australia 2001. AIHW cat. no. CAN 23. Canberra: AIHW (cancer series no. 28), 2004.
30. Plaschke J., Engel C., Kruger S., et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations. the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22 (2004) 4486-4494
31. Muller A., and Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 20 (2002) 102-109
32. Easton D.F., Hopper J.L., Thomas D.C., et al. Breast cancer risks for BRCA1/2 carriers. Science 306 (2004) 2187-2191
33. Watson P., Ashwathnarayan R., Lynch H.T., et al. Tobacco use and increased colorectal cancer risk in cases with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med 164 (2004) 2429-2431
34. De Jong A.E., Morreau H., Van Puijenbroek M., et al. The role of mismatch repair gene defects in the development of adenomas in cases with HNPCC. Gastroenterology 126 (2004) 42-48